{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:05:55Z","timestamp":1782957955600,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.dsx.2021.102261","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:55:28Z","timestamp":1629849328000},"page":"102261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Retrospective analysis (2009\u20132017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-7246","authenticated-orcid":false,"given":"Nithyanantham","family":"Kamalraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhanagopal","family":"Sathishkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-5318","authenticated-orcid":false,"given":"Mani","family":"Arunvignesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-2550","authenticated-orcid":false,"given":"Viswanathan","family":"Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Jebarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9974-889X","authenticated-orcid":false,"given":"Anandakumar","family":"Amutha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Deepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coimbatore Subramanyam","family":"Shanthi Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaramoorthy","family":"Chandru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit Mohan","family":"Anjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardavada","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-6210","authenticated-orcid":false,"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.102261_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.dsx.2021.102261_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.23521","article-title":"Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?","volume":"51","author":"Angulo","year":"2010","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.dsx.2021.102261_bib3","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.dsx.2021.102261_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","article-title":"Non-alcoholic fatty liver disease: the diagnosis and management","volume":"7","author":"Abd El-Kader","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.dsx.2021.102261_bib6","first-page":"H31","article-title":"Prevalence and profile of non-alcoholic fatty liver disease among adults undergoing master health checkup, a hospital based cross sectional study","volume":"6","author":"Sangeetha","year":"2019","journal-title":"International Journal of Contemporary Medical Research"},{"key":"10.1016\/j.dsx.2021.102261_bib7","first-page":"105","article-title":"Comparative analyses of genetic risk prediction methods reveal extreme diversity of genetic predisposition to nonalcoholic fatty liver disease (NAFLD) among ethnic populations of India","volume":"94","author":"Chatterjee","year":"2015","journal-title":"J\u00a0Genet"},{"issue":"6","key":"10.1016\/j.dsx.2021.102261_bib8","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.dsx.2020.11.015","article-title":"Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"11","key":"10.1016\/j.dsx.2021.102261_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142260","article-title":"Phenotype, body composition, and prediction equations (Indian fatty liver index) for non-alcoholic fatty liver disease in non-diabetic asian Indians: a case-control study","volume":"10","author":"Bhatt","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.dsx.2021.102261_bib10","first-page":"76","article-title":"Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey","volume":"25","author":"Singh","year":"2004","journal-title":"Trop Gastroenterol"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.dsx.2021.102261_bib12","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/db13-1592","article-title":"Diabetes in south asians: is the Phenotype different?","volume":"63","author":"Unnikrishnan","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.dsx.2021.102261_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/193229681100500309","article-title":"Use of a large diabetes electronic medical record system in India: clinical and research applications","volume":"5","author":"Pradeepa","year":"2011","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"6","key":"10.1016\/j.dsx.2021.102261_bib15","doi-asserted-by":"crossref","first-page":"499e502","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2021.102261_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dmrr.658","article-title":"Prevalence of metabolic syndrome using WHO, ATP III and IDF definitions in asian Indians \u2013 the Chennai urban rural epidemiology study (CURES \u2013 34)","volume":"23","author":"Deepa","year":"2007","journal-title":"Diabet. Metab. Res. Rev."},{"key":"10.1016\/j.dsx.2021.102261_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2021.102261_bib18","first-page":"409","article-title":"Glycaemic and insulin responses to some breakfast items in diabetic subjects","volume":"37","author":"Viswanathan","year":"1988","journal-title":"Nutr Rep Int"},{"key":"10.1016\/j.dsx.2021.102261_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pcd.2011.04.003","article-title":"Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in South India","volume":"5","author":"Amutha","year":"2011","journal-title":"Prim Care Diabetes"},{"issue":"6","key":"10.1016\/j.dsx.2021.102261_bib20","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/dia.2013.0165","article-title":"Comparison of characteristics between nonobese and overweight\/obese subjects with nonalcoholic fatty liver disease in a South Indian population","volume":"16","author":"Vendhan","year":"2014","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2021.102261_bib22","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2021.102261_bib23","series-title":"Western Pacific region: the Asia Pacific Perspective. Redefining obesity and its treatment","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.dsx.2021.102261_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/00365520500319591","article-title":"Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study","volume":"41","author":"Lee","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dsx.2021.102261_bib25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1440-1746.2002.02846.x","article-title":"Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics","volume":"17","author":"Omagari","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"Issue 12","key":"10.1016\/j.dsx.2021.102261_bib26","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.dsx.2021.102261_bib27","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.dsx.2019.01.054","article-title":"Nutrition and physical activity in Asian Indians with non-alcoholic fatty liver: a case control study","volume":"13","author":"Bhatt","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.102261_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.dsx.2021.102261_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dsx.2021.102261_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1467-789X.2003.00108.x","article-title":"Central obesity and breast cancer risk: a systematic review","volume":"4","author":"Harvie","year":"2003","journal-title":"Obes Rev"},{"key":"10.1016\/j.dsx.2021.102261_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.dsx.2021.102261_bib32","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dsx.2021.102261_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.dsx.2020.05.019","article-title":"From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): a journey over 40 years","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2021.102261_bib34","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.5551\/jat1994.2.Supplement1_S47","article-title":"Hypertriglyceridemia and fatty liver: clinical diagnosis of fatty liver and lipoprotein profiles in hypertriglyceridemic patients with fatty liver","volume":"2","author":"Osono","year":"1995","journal-title":"J\u00a0Atherosclerosis Thromb"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049286","article-title":"Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on asian Indians in North India","volume":"8","author":"Nigam","year":"2013","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.dsx.2021.102261_bib36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1440-1746.2006.04615.x","article-title":"Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan","volume":"22","author":"Chen","year":"2007","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian national association for the study of the liver, endocrine society of India, Indian College of cardiology and Indian society of gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.dsx.2021.102261_bib38","doi-asserted-by":"crossref","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J Endocr Metab"},{"issue":"6","key":"10.1016\/j.dsx.2021.102261_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","article-title":"World Gastroenterology Organisation. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"LaBrecque","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.dsx.2021.102261_bib40","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","article-title":"Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"25","author":"Zhang","year":"2014","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dsx.2021.102261_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.dsx.2021.102261_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.dsx.2021.102261_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/ijms17040479","article-title":"Different serum free fatty acid profiles in NAFLD subjects and healthy controls after oral fat load","volume":"17","author":"Gambino","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.dsx.2021.102261_bib44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4093\/dmj.2012.36.4.262","article-title":"GLP-1 receptor agonist and non-alcoholic fatty liver disease","volume":"36","author":"Lee","year":"2012","journal-title":"Diabetes & Metabolism Journal"},{"key":"10.1016\/j.dsx.2021.102261_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib46","first-page":"18","article-title":"The effects of hypoglycemic agents on non-alcoholic fatty liver disease: focused on sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor Agonists","volume":"28","author":"Jung","year":"2019","journal-title":"J\u00a0ObesMetabSyndr"},{"key":"10.1016\/j.dsx.2021.102261_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13098-021-00644-5","article-title":"Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis","volume":"13","author":"Hattori","year":"2021","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2021.102261_bib48","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00125-018-4675-2","article-title":"Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study","volume":"61","author":"Eriksson","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.dsx.2021.102261_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.dsx.2021.102261_bib50","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dsx.2021.102261_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:18:00Z","timestamp":1761729480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121002812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1871402121002812"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102261","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis (2009\u20132017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102261"}}